Shailesh joined LGM Pharma in 2019, bringing extensive CMC, regulatory, and management experience in NDA, ANDA, and BLA submissions. He also has a proven track record in process development, formulation, analytical and bioanalytical method development, supply chain, metabolism, and other non-clinical studies. With 35+ years in the pharmaceutical industry, Shailesh makes effective use of science to drive quality, operational, and business efficiency. He has been able to rapidly create strategy into a guiding vision in a change-oriented environment.
Prior to LGM, he was VP of Pharmaceutical Development at Palatin Tech; and a manager at Ranbaxy Pharmaceuticals, and Analytical Bio-Chemistry Laboratories. Shailesh began his career as an analytical development scientist.
Ian leads LGM operations for our CDMO business. He joined LGM in 2020, having held various roles of increasing responsibility with Nexgen Pharma and its predecessor Anabolic Laboratories.
He started his career in geotechnical engineering, then became a pharmaceutical production engineer at Anabolic Labs. Throughout his Nexgen career, he served as VP Operations, overseeing three plants and a major remodel; as President, overseeing Rx sales, R&D, Quality, and Manufacturing and Packaging Operations; as Assistant CFO; and, most recently, EVP Rx Operations, overseeing 2 plants for oral solid dose and semi-solid/liquid dosage forms.
Ian earned bachelor’s and master’s degrees in civil engineering from Virginia Tech and an MBA from the University of Hawaii.